Morgan Stanley Tempest Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 100,151 shares of TPST stock, worth $88,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,151

Previous 62,736 59.64%

Holding current value

$88,132

Previous $137,000 2.19%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.96 - $2.23 $35,918 - $83,435	37,415 Added 59.64%	100,151 $140,000
Q2 2024 Oct 17, 2024	BUY	$2.01 - $5.44 $52,149 - $141,140	25,945 Added 70.52%	62,736 $137,000
Q2 2024 Aug 14, 2024	BUY	$2.01 - $5.44 $52,149 - $141,140	25,945 Added 70.52%	62,736 $137,000
Q1 2024 Oct 17, 2024	SELL	$3.16 - $4.66 $81,986 - $120,903	-25,945 Reduced 41.36%	36,791 $143,000
Q1 2024 Aug 16, 2024	BUY	$3.16 - $4.66 $15,721 - $23,183	4,975 Added 15.64%	36,791 $143,000
Q1 2024 May 15, 2024	BUY	$3.16 - $4.66 $15,721 - $23,183	4,975 Added 15.64%	36,791 $143,000
Q4 2023 Aug 16, 2024	SELL	$0.23 - $9.77 $7,111 - $302,088	-30,920 Reduced 49.29%	31,816 $139,000
Q4 2023 Feb 13, 2024	BUY	$0.23 - $9.77 $7,223 - $306,826	31,405 Added 7641.12%	31,816 $139,000
Q3 2023 Nov 15, 2023	SELL	$0.3 - $1.39 $16 - $75	-54 Reduced 11.61%	411 $0
Q2 2023 Aug 14, 2023	SELL	$1.12 - $3.76 $33 - $112	-30 Reduced 6.06%	465 $0
Q1 2023 May 15, 2023	SELL	$1.14 - $2.91 $74 - $189	-65 Reduced 11.61%	495 $1,000
Q2 2022 Oct 27, 2022	SELL	$2.08 - $4.15 $3,155 - $6,295	-1,517 Reduced 73.04%	560 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.08 - $4.15 $3,155 - $6,295	-1,517 Reduced 73.04%	560 $1,000
Q1 2022 Oct 27, 2022	BUY	$2.27 - $5.45 $3,443 - $8,267	1,517 Added 270.89%	2,077 $7,000
Q1 2022 May 13, 2022	BUY	$2.27 - $5.45 $621 - $1,493	274 Added 15.2%	2,077 $7,000
Q4 2021 Feb 14, 2022	SELL	$5.28 - $15.2 $982 - $2,827	-186 Reduced 9.35%	1,803 $10,000
Q3 2021 Nov 15, 2021	BUY	$10.49 - $24.19 $20,864 - $48,113	1,989 New	1,989 $29,000

Others Institutions Holding TPST

# of Institutions

Shares Held

2.4M

Call Options Held

44.9K

Put Options Held

109K

View Full List

About Tempest Therapeutics, Inc.

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $9.17M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

More about TPST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account